Steven V. Molinski

1.3k total citations
19 papers, 874 citations indexed

About

Steven V. Molinski is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Steven V. Molinski has authored 19 papers receiving a total of 874 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 10 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Steven V. Molinski's work include Cystic Fibrosis Research Advances (12 papers), Neonatal Respiratory Health Research (8 papers) and Advanced biosensing and bioanalysis techniques (6 papers). Steven V. Molinski is often cited by papers focused on Cystic Fibrosis Research Advances (12 papers), Neonatal Respiratory Health Research (8 papers) and Advanced biosensing and bioanalysis techniques (6 papers). Steven V. Molinski collaborates with scholars based in Canada, United States and United Kingdom. Steven V. Molinski's co-authors include Christine E. Bear, Susan P.C. Cole, Vijay Shahani, Saumel Ahmadi, Lindsay Smith, J. Javier Hernández, Connor Yanchus, Onofrio Laselva, Valeria Casavola and Stan Pasyk and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Biochemical Journal.

In The Last Decade

Steven V. Molinski

19 papers receiving 866 citations

Peers

Countries citing papers authored by Steven V. Molinski

Since Specialization

Citations

This map shows the geographic impact of Steven V. Molinski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven V. Molinski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven V. Molinski more than expected).

Fields of papers citing papers by Steven V. Molinski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven V. Molinski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven V. Molinski. The network helps show where Steven V. Molinski may publish in the future.

Co-authorship network of co-authors of Steven V. Molinski

This figure shows the co-authorship network connecting the top 25 collaborators of Steven V. Molinski. A scholar is included among the top collaborators of Steven V. Molinski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven V. Molinski. Steven V. Molinski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Comprehensive mapping of cystic fibrosis mutations to CFTR protein identifies mutation clusters and molecular docking predicts corrector binding site 2018 ·Proteins Structure Function and Bioinformatics ·Steven V. Molinski, Vijay Shahani, (unknown), (unknown), (unknown), (unknown), Onofrio Laselva, (unknown), Christine E. Bear, Andreas Windemuth	49
2	Correctors of the Major Cystic Fibrosis Mutant Interact through Membrane-Spanning Domains 2018 ·Molecular Pharmacology ·Onofrio Laselva, Steven V. Molinski, Valeria Casavola, Christine E. Bear	49
3	Phenotypic profiling of CFTR modulators in patient-derived respiratory epithelia 2017 ·npj Genomic Medicine ·Saumel Ahmadi, Zoltán Bozóky, Michelle Di Paola, Sunny Xia, Canhui Li, Amy P. Wong, Leigh Wellhauser, Steven V. Molinski, Wan Ip, Hong Ouyang, Julie Avolio, Julie D. Forman‐Kay, Félix Ratjen, Jeremy A. Hirota, Johanna M. Rommens, Janet Rossant, Tanja Gonska, Theo J. Moraes, Christine E. Bear	57
4	Giving Drugs a Second Chance: Overcoming Regulatory and Financial Hurdles in Repurposing Approved Drugs As Cancer Therapeutics 2017 ·Frontiers in Oncology ·J. Javier Hernández, (unknown), Lindsay Smith, Connor Yanchus, (unknown), Vijay Shahani, Steven V. Molinski	198
5	Biophysical Approaches Facilitate Computational Drug Discovery for ATP-Binding Cassette Proteins 2017 ·PubMed ·Steven V. Molinski, Zoltán Bozóky, Surtaj H. Iram, Saumel Ahmadi	6
6	The Antiretroviral Agent Nelfinavir Mesylate 2017 ·Arthritis & Rheumatology ·Cecilia G. Sánchez, Steven V. Molinski, Rafael Góngora, (unknown), Taylor Fuselier, (unknown), Debasis Mondal, Joseph A. Lasky	12
7	Attenuation of Phosphorylation-dependent Activation of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) by Disease-causing Mutations at the Transmission Interface 2016 ·Journal of Biological Chemistry ·Stephanie Chin, Donghe Yang, Andrew J. Miles, Paul D. W. Eckford, Steven V. Molinski, B.A. Wallace, Christine E. Bear	6
8	Computational proteome-wide screening predicts neurotoxic drug-protein interactome for the investigational analgesic BIA 10-2474 2016 ·Biochemical and Biophysical Research Communications ·Steven V. Molinski, Vijay Shahani, (unknown), (unknown), (unknown), (unknown), (unknown), Cecilia G. Sánchez, Shoshana J. Wodak, Andreas Windemuth	13
9	The investigational Cystic Fibrosis drug Trimethylangelicin directly modulates CFTR by stabilizing the first membrane-spanning domain 2016 ·Biochemical Pharmacology ·Onofrio Laselva, Steven V. Molinski, Valeria Casavola, Christine E. Bear	34
10	Facilitating Structure-Function Studies of CFTR Modulator Sites with Efficiencies in Mutagenesis and Functional Screening 2015 ·SLAS DISCOVERY ·Steven V. Molinski, Saumel Ahmadi, (unknown), Christine E. Bear	33
11	Sphingosine-1-Phosphate Is a Novel Regulator of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Activity 2015 ·PLoS ONE ·(unknown), Anja Meißner, (unknown), Steven V. Molinski, Stan Pasyk, Saumel Ahmadi, Hai H. Bui, Christine E. Bear, Darcy Lidington, Steffen-Sebastian Bolz	31
12	Genetic, cell biological, and clinical interrogation of theCFTR mutation c.3700 A>G (p.Ile1234Val) informs strategies for future medical intervention 2014 ·Genetics in Medicine ·Steven V. Molinski, Tanja Gonska, Ling Jun Huan, Berivan Baskin, Ibrahim Janahi, Peter N. Ray, Christine E. Bear	29
13	VX-809 and Related Corrector Compounds Exhibit Secondary Activity Stabilizing Active F508del-CFTR after Its Partial Rescue to the Cell Surface 2014 ·Chemistry & Biology ·Paul D. W. Eckford, Mohabir Ramjeesingh, Steven V. Molinski, Stan Pasyk, Johanna F. Dekkers, Canhui Li, Saumel Ahmadi, Wan Ip, Timothy Chung, Kai Du, Herman Yeger, Jeffrey M. Beekman, Tanja Gonska, Christine E. Bear	78
14	The major cystic fibrosis causing mutation exhibits defective propensity for phosphorylation 2014 ·PROTEOMICS ·Stan Pasyk, Steven V. Molinski, Saumel Ahmadi, Mohabir Ramjeesingh, Ling‐Jun Huan, Stephanie Chin, Kai Du, Herman Yeger, Paul Taylor, Michael F. Moran, Christine E. Bear	19
15	Conformational defects underlie proteasomal degradation of Dent's disease-causing mutants of ClC-5 2013 ·Biochemical Journal ·(unknown), Steven V. Molinski, Saumel Ahmadi, Ling‐Jun Huan, Leigh Wellhauser, Christine E. Bear	20
16	Functional Rescue of F508del-CFTR Using Small Molecule Correctors 2012 ·Frontiers in Pharmacology ·Steven V. Molinski, Paul D. W. Eckford, Stan Pasyk, Saumel Ahmadi, Stephanie Chin, Christine E. Bear	39
17	Identification and Validation of Hits from High Throughput Screens for CFTR Modulators 2012 ·Current Pharmaceutical Design ·Stan Pasyk, Steven V. Molinski, Wilson Yu, Paul D. W. Eckford, Christine E. Bear	9
18	Mammalian multidrug-resistance proteins (MRPs) 2011 ·Essays in Biochemistry ·(unknown), Steven V. Molinski, Susan P.C. Cole	175
19	Platelet and red blood cell phagocytosis kinetics are differentially controlled by phosphatase activity within mononuclear cells 2007 ·Transfusion ·Rukhsana Aslam, Michael Kim, Edwin R. Speck, (unknown), Steven V. Molinski, John Freedman, John W. Semple	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact